Related Articles
Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer
Immunological evaluation of personalized peptide vaccination for patients with pancreatic cancer
Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens
Personalized peptide vaccination in patients with refractory non-small cell lung cancer
A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patients